Transplanted human olfactory ensheathing cells (hOECs) were mixed with collagen into a unilateral transection of four dorsal roots (C6–T1) in a rat model. By mixing with collagen, the limited numbers of hOEC were maximized from an olfactory bulb biopsy and optimize cavity filling. Cyclosporine was administered daily to prevent immune rejection. Forelimb proprioception was assessed weekly in a vertical climb task. Half of the rats receiving hOEC transplants showed some functional improvement (“responders”) over six weeks of the study while the other half did not (“nonresponders”) and performed similarly to “injured only” rats.
Transplanted cells were seen at both one week and six weeks after the surgical procedure; many were concentrated within the lesion cavity, but others were found with elongated processes in the overlying connective tissue. There were some fibers in the injury area associated with transplanted cells that were immunostained for neurofilament and TUJ1. Responder and nonresponder rats were compared with regard to microglial activation within the deep dorsal horn of cervical levels C7, C8 and also axon loss within the cuneate fasciculus at cervical level C3. Little difference was seen in microglial activation or axonal loss that could account for the improved proprioception in the responders group. This preliminary study is the first to transplant human olfactory bulb cells into a rat model of dorsal root injury; by refining each component part of the procedure, the repair potential of OECs can be maximized in a clinical setting.
Get full access to this article
View all access options for this article.
References
1.
BertelliJ.A., GhizoniM.F., and Loure Iro ChavesD.P. (2011). Sensory disturbances and pain complaints after brachial plexus root injury: a prospective study involving 150 adult patients. Microsurgery, 31, 93–97.
HtutM., MisraP., AnandP., BirchR., and CarlstedtT. (2006). Pain phenomena and sensory recovery following brachial plexus avulsion injury and surgical repairs. J. Hand Surg. Br., 31, 596–605.
4.
GiuffreJ.L., KakarS., BishopA.T., SpinnerR.J., and ShinA.Y. (2010). Current concepts of the treatment of adult brachial plexus injuries. J. Hand Surg. Am., 35, 678–88.
5.
KachramanoglouC., LiD., AndrewsP., EastC., CarlstedtT., RaismanG., and ChoiD. (2011). Novel strategies in brachial plexus repair after traumatic avulsion. Br. J. Neurosurg., 25, 16–27.
6.
LimthongthangR., BachouraA., SongcharoenP., and OstermanA.L. (2013). Adult brachial plexus injury: evaluation and management. Orthop. Clin. North Am., 44, 591–603.
7.
GraziadeiP.P. and GraziadeiG.A. (1979). Neurogenesis and neuron regeneration in the olfactory system of mammals. I. Morphological aspects of differentiation and structural organization of the olfactory sensory neurons. J. Neurocytol., 8, 1–18.
8.
PlantG.W., HarveyA.R., LeaverS.G., and LeeS.V. (2011). Olfactory ensheathing glia: repairing injury to the mammalian visual system. Exp. Neurol., 229, 99–108.
9.
RaismanG. (2007). Repair of spinal cord injury by transplantation of olfactory ensheathing cells. C R Biol. 330, 557–560.
10.
RoetK.C. and VerhaagenJ. (2014). Understanding the neural repair-promoting properties of olfactory ensheathing cells. Exp. Neurol., 261, 594–609.
11.
FranklinR.J., GilsonJ.M., FranceschiniI.A., and BarnettS.C. (1996). Schwann cell-like myelination following transplantation of an olfactory bulb-ensheathing cell line into areas of demyelination in the adult CNS. Glia, 17, 217–224.
12.
KocsisJ.D., LankfordK.L., SasakiM., and RadtkeC. (2009). Unique in vivo properties of olfactory ensheathing cells that may contribute to neural repair and protection following spinal cord injury. Neurosci. Lett., 456, 137–142.
13.
RamerL.M., AuE., RichterM.W., LiuJ., TetzlaffW., and RoskamsA.J. (2004). Peripheral olfactory ensheathing cells reduce scar and cavity formation and promote regeneration after spinal cord injury. J. Comp. Neurol., 473, 1–15.
14.
ToftA., ScottD.T., BarnettS.C., and RiddellJ.S. (2007). Electrophysiological evidence that olfactory cell transplants improve function after spinal cord injury. Brain, 130, 970–984.
15.
ZieglerM.D., HsuD., TakeokaA., ZhongH., Ramon-CuetoA., PhelpsP.E., RoyR.R., and EdgertonV.R. (2011). Further evidence of olfactory ensheathing glia facilitating axonal regeneration after a complete spinal cord transection. Exp. Neurol., 229, 109–119.
16.
IbrahimA.G., KirkwoodP.A., RaismanG., and LiY. (2009). Restoration of hand function in a rat model of repair of brachial plexus injury. Brain, 132, 1268–1276.
17.
Keyvan-FouladiN., RaismanG., and LiY. (2003). Functional repair of the corticospinal tract by delayed transplantation of olfactory ensheathing cells in adult rats. J. Neurosci., 23, 9428–9434.
18.
LiY., DecherchiP., and RaismanG. (2003). Transplantation of olfactory ensheathing cells into spinal cord lesions restores breathing and climbing. J. Neurosci., 23, 727–731.
19.
LiY., FieldP., and RaismanG. (1997). Repair of adult rat corticospinal tract by transplants of olfactory ensheathing cells. Science, 277, 2000–2002.
20.
LuJ., FeronF., Mackay-SimA., and WaiteP.M. (2002). Olfactory ensheathing cells promote locomotor recovery after delayed transplantation into transected spinal cord. Brain, 125, 14–21.
21.
Ramon-CuetoA., CorderoM.I., Santos-BenitoF.F., and AvilaJ. (2000). Functional recovery of paraplegic rats and motor axon regeneration in their spinal cords by olfactory ensheathing glia. Neuron, 25, 425–435.
22.
GrangerN., BlamiresH., FranklinR.J., and JefferyN.D. (2012). Autologous olfactory mucosal cell transplants in clinical spinal cord injury: a randomized double-blinded trial in a canine translational model. Brain, 135, 3227–3237.
23.
LimaC., EscadaP., Pratas-VitalJ., BrancoC., ArcangeliC.A., LazzeriG., MaiaC.A., CapuchoC., Hasse-FerreiraA., and PeduzziJ.D. (2010). Olfactory mucosal autografts and rehabilitation for chronic traumatic spinal cord injury. Neurorehabil. Neural Repair, 24, 10–22.
24.
LimaC., Pratas-VitalJ., EscadaP., Hasse-FerreiraA., CapuchoC., and PeduzziJ.D. (2006). Olfactory mucosa autografts in human spinal cord injury: a pilot clinical study. J. Spinal Cord Med., 29, 191–203.
25.
TabakowP., JarmundowiczW., CzapigaB., FortunaW., MiedzybrodzkiR., CzyzM., HuberJ., SzarekD., OkurowskiS., SzewczykP., GorskiA., and RaismanG. (2013). Transplantation of autologous olfactory ensheathing cells in complete human spinal cord injury. Cell Transplant. 22, 1591–1612.
26.
ChhabraH.S., LimaC., SachdevaS., MittalA., NigamV., ChaturvediD., AroraM., AggarwalA., KapurR., and KhanT.A. (2009). Autologous olfactory [corrected] mucosal transplant in chronic spinal cord injury: an Indian Pilot Study. Spinal Cord, 47, 887–895.
27.
FeronF., PerryC., CochraneJ., LicinaP., NowitzkeA., UrquhartS., GeraghtyT., and Mackay-SimA. (2005). Autologous olfactory ensheathing cell transplantation in human spinal cord injury. Brain, 128, 2951–2960.
28.
Mackay-SimA., FeronF., CochraneJ., BassingthwaighteL., BaylissC., DaviesW., FronekP., GrayC., KerrG., LicinaP., NowitzkeA., PerryC., SilburnP.A., UrquhartS., and GeraghtyT. (2008). Autologous olfactory ensheathing cell transplantation in human paraplegia: a 3-year clinical trial. Brain, 131, 2376–2386.
29.
TabakowP., RaismanG., FortunaW., CzyzM., HuberJ., LiD., SzewczykP., OkurowskiS., MiedzybrodzkiR., CzapigaB., SalomonB., HalonA., LiY., LipiecJ., KulczykA., and JarmundowiczW. (2014). Functional regeneration of supraspinal connections in a patient with transected spinal cord following transplantation of bulbar olfactory ensheathing cells with peripheral nerve bridging. Cell Transplant. 23, 1631–1655.
30.
BoruchA.V., ConnersJ.J., PipitoneM., DeadwylerG., StorerP.D., DevriesG.H., and JonesK.J. (2001). Neurotrophic and migratory properties of an olfactory ensheathing cell line. Glia. 33, 225-9.
RuitenbergM.J., PlantG.W., ChristensenC.L., BlitsB., NiclouS.P., HarveyA.R., BoerG.J., and VerhaagenJ. (2002). Viral vector-mediated gene expression in olfactory ensheathing glia implants in the lesioned rat spinal cord. Gene Ther. 9, 135–146.
33.
IbrahimA.G., RaismanG., and LiY. (2009). Permanent loss of fore-paw grasping requires complete deprivation of afferent input from a minimum of four dorsal roots of the rat brachial plexus. Exp. Neurol., 215, 142–145.
34.
HinwoodM., TynanR.J., CharnleyJ.L., BeynonS.B., DayT.A., and WalkerF.R. (2013). Chronic stress induced remodeling of the prefrontal cortex: structural re-organization of microglia and the inhibitory effect of minocycline. Cereb. Cortex, 23, 1784–1797.
35.
AhujaC.S. and FehlingsM. (2016). Concise review: bridging the gap: novel neuroregenerative and neuroprotective strategies in spinal cord injury. Stem Cells Transl. Med., 5, 914–924.
36.
HurtadoA., CreggJ.M., WangH.B., WendellD.F., OudegaM., GilbertR.J., and McDonaldJ.W. (2011). Robust CNS regeneration after complete spinal cord transection using aligned poly-L-lactic acid microfibers. Biomaterials, 32, 6068–6079.
37.
DengC., GorrieC., HaywardI., ElstonB., VennM., Mackay-SimA., and WaiteP. (2006). Survival and migration of human and rat olfactory ensheathing cells in intact and injured spinal cord. J. Neurosci. Res., 83, 1201–1212.
38.
LiY., CarlstedtT., BertholdC.H., and RaismanG. (2004). Interaction of transplanted olfactory-ensheathing cells and host astrocytic processes provides a bridge for axons to regenerate across the dorsal root entry zone. Exp. Neurol., 188, 300–308.
39.
IbrahimA., LiD., CollinsA., TabakowP., RaismanG., and LiY. (2014). Comparison of olfactory bulbar and mucosal cultures in a rat rhizotomy model. Cell Transplant. 23, 1465–1470.
40.
GuestJ.D., HerreraL., MargitichI., OliveriaM., MarcilloA., and CasasC.E. (2008). Xenografts of expanded primate olfactory ensheathing glia support transient behavioral recovery that is independent of serotonergic or corticospinal axonal regeneration in nude rats following spinal cord transection. Exp. Neurol., 212, 261–274.
41.
GorrieC.A., HaywardI., CameronN., KailainathanG., NandapalanN., SutharsanR., WangJ., Mackay-SimA., and WaiteP.M. (2010). Effects of human OEC-derived cell transplants in rodent spinal cord contusion injury. Brain Res. 1337, 8–20.
42.
KatoT., HonmouO., UedeT., HashiK., and KocsisJ.D. (2000). Transplantation of human olfactory ensheathing cells elicits remyelination of demyelinated rat spinal cord. Glia, 30, 209–218.
43.
BarnettS.C., AlexanderC.L., IwashitaY., GilsonJ.M., CrowtherJ., ClarkL., DunnL.T., PapanastassiouV., KennedyP.G., and FranklinR.J. (2000). Identification of a human olfactory ensheathing cell that can effect transplant-mediated remyelination of demyelinated CNS axons. Brain, 123, 1581–1588.
44.
LindsayS.L., RiddellJ.S., and BarnettS.C. (2010). Olfactory mucosa for transplant-mediated repair: a complex tissue for a complex injury?. Glia, 58, 125–134.
45.
LlamusiM.B., RubioM.P., and Ramon-CuetoA. (2011). Telomerase protects adult rodent olfactory ensheathing glia from early senescence. Exp. Neurol., 229, 54–64.
46.
BhatnagarK.P., KennedyR.C., BaronG., and GreenbergR.A. (1987). Number of mitral cells and the bulb volume in the aging human olfactory bulb: a quantitative morphological study. Anat. Rec., 218, 73–87.
47.
MareshA., Rodriguez GilD., WhitmanM.C., and GreerC.A. (2008). Principles of glomerular organization in the human olfactory bulb—implications for odor processing. PLoS One, 3, e2640.
48.
MeisamiE., MikhailL., BaimD., and BhatnagarK.P. (1998). Human olfactory bulb: aging of glomeruli and mitral cells and a search for the accessory olfactory bulb. Ann. N. Y. Acad. Sci., 855, 708–715.
49.
GeorgeR. and GriffinJ.W. (1994). The proximo-distal spread of axonal degeneration in the dorsal columns of the rat. J. Neurocytol., 23, 657–67.
50.
NiuJ., DingL., LiJ.J., KimH., LiuJ., LiH., MoberlyA., BadeaT.C., DuncanI.D., SonY.J., SchererS.S., and LuoW. (2013). Modality-based organization of ascending somatosensory axons in the direct dorsal column pathway. J. Neurosci., 33, 17691–17709.
51.
CollinsA., LiD., McMahonS.B., RaismanG., and LiY. (2017). Transplantation of cultured olfactory bulb cells prevents abnormal sensory responses during recovery from dorsal root avulsion in the rat. Cell Transplant. 26, 913–924.
52.
MarchandF., PerrettiM., and McMahonS.B. (2005). Role of the immune system in chronic pain. Nat. Rev. Neurosci., 6, 521–532.
53.
SchwabJ.M., ZhangY., KoppM.A., BrommerB., and PopovichP.G. (2014). The paradox of chronic neuroinflammation, systemic immune suppression, autoimmunity after traumatic chronic spinal cord injury. Exp. Neurol., 258, 121–129.
54.
AnwarM.A., Al ShehabiT.S., and EidA.H. (2016). Inflammogenesis of secondary spinal cord injury. Front. Cell. Neurosci., 10, 98.
55.
SuterM.R., BertaT., GaoY.J., DecosterdI., and JiR.R. (2009). Large A-fiber activity is required for microglial proliferation and p38 MAPK activation in the spinal cord: different effects of resiniferatoxin and bupivacaine on spinal microglial changes after spared nerve injury. Mol. Pain, 5, 53.
